CD8A and neoplasm: Together these studies suggest that while the exact T-cell tumor infiltration kinetics may vary depending on the murine model and RT dose, close sequencing of checkpoint blockade following RT should be the goal to take advantage of the peak in tumor effector CD8 T-cells.